Loargys : Immedica advances enzyme replacement for ARG1-D under accelerated approval Loargys On February 23, Immedica Pharma secured accelerated approval for Loargys (pegzilarginase-nbln) injection for hyperargininemia in adults and pediatric patients aged 2 years and older with arginase 1 deficiency, in conjunction with dietary protein restriction
Non-arteritic anterior ischemic optic neuropathy, or NAION, is a condition where blood flow to your optic nerve suddenly decreases
Similar content being viewed by others Introduction Seriously ill patients who suffered a life-threatening event, for instance major trauma, surgery, or infection 1 , frequently require intensive care unit (ICU) support
Advanced Anti-Aging and Collagen Synthesis GHK-Cu is a powerful collagen booster
Key Takeaways: Liposomal glutathione offers superior absorption, enabling more efficient delivery of antioxidants and immune support than traditional supplements